Nulojix (Belatacept)

Nulojix (belatacept) is a selective T-cell costimulation blocker used for prophylaxis of organ rejection in adult patients receiving a kidney transplant. This therapeutic drug is used together with basiliximab induction, mycophenolate mofetil, and corticosteroids.

Limitations of Use: Use this therapeutic drug only in those who are EBV seropositive. Its use has not been evaluated for the prophylaxis of organ rejection in transplanted organs other than the kidney.

Recommended Dosage: The recommended dosage of Nulojix 250 mg injection is administered in combination with basiliximab induction, mycophenolate mofetil (MMF), and corticosteroids. It is intravenous (IV) infusion only
Usual Adult Dose for Rejection Prophylaxis:

• Initial phase dose: The recommended initial phase dose is 10 mg/kg IV on Day 1 (day of transplant, before implantation) and Day 5 (approximately 96 hours after Day 1 dose), and at the end of Weeks 2, 4, 8, and 12 after transplantation.
• Maintenance phase dose: The recommended maintenance phase dose is 5 mg/kg IV at the end of Week 16 after transplantation and every 4 weeks (plus or minus 3 days) thereafter.

Usual Adult Dose for Renal Transplant:

• Initial phase dose: The recommended initial phase dose is 10 mg/kg IV on Day 1 (day of transplant, before implantation) and Day 5 (approximately 96 hours after Day 1 dose), and at the end of Weeks 2, 4, 8, and 12 after transplantation.
• Maintenance phase dose: The recommended maintenance phase dose is 5 mg/kg IV at the end of Week 16 after transplantation and every 4 weeks (plus or minus 3 days) thereafter.

• Treatment with Nulojix 250 mg injection increases the likelihood of acquiring PTLD, which is characterized by uncontrolled growth of lymphoid cells after transplantation. PTLD needs to be ruled out on the suspicion during the first year after the transplant.
• As an immunosuppressive drug, Nulojix needs to be used meticulously within the framework of primary care to avoid severe infection and simultaneously, excessive immune system suppression while managing organ rejection.
• Some cancers are prone to appear with prolonged use of this therapeutic drug. During the treatment and even after the therapy, patients need to be checked regularly for the development of these malignancies, especially skin cancer.
• This medicine may be responsible for increasing the risk of PML. It is a serious brain infection. Patients with signs of neurological decline should be promptly evaluated for this condition and discontinued from treatment if diagnosed.
• The use of this medicine increases the risk of countless bacterial, viral, fungal, and parasitic infections because of its immunosuppressant nature. Signs of infection require close surveillance and immediate action in order to avoid complications.
• Caution should be exercised for patients with a liver transplant when using this medicine because of risks such as liver dysfunction. While on treatment, periodic liver function assessments need to be done to check for these negative side effects.
• Administration of live vaccines is contraindicated for patients receiving this treatment, because of the risk of serious infection or lack of effectiveness. Inactivated vaccines may be given at the appropriate time, either before or after treatment.
• This medicinal product may elevate the infection or other complication risks when used in conjunction with anti-thymocyte globulin. Cautious use of monitoring and adjusting the immunosuppressant may be required with active coadministration.
• Nulojix is contraindicated during pregnancy due to the risk of fetal harm. Women of childbearing age should receive appropriate counseling regarding the risks. If the patient is on this treatment and a pregnancy occurs, the health provider should be contacted immediately to inform for proper risk evaluation and management.
• It is not known whether Belatacept is transferred into breast milk. Because of the risk of serious damage, breastfeeding is not advised while on treatment with Belatacept. Contact a medical professional regarding the need to cease breastfeeding or consider other alternatives.

What documents are required to import NULOJIX to India?

NULOJIX (belatacept) injections can be imported by patients or government hospitals on the name of the patients only.

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

• The order will be confirmed only after the receipt of:
• A valid prescription from the Doctor
• Import permit if applicable

Is NULOJIX available in India?

NULOJIX (belatacept injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Nulojix in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait,
• Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

NULOJIX can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of NULOJIX (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Nulojix 250 mg injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source NULOJIX (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Nulojix®?

Belatacept is a Generic Name for the trade name drug Nulojix®.

What is the Manufacturer's Name of Nulojix®?

Nulojix® is manufactured by Bristol-Myers Squibb Company.

Is Nulojix approved by the FDA?

Yes, Nulojix® is approved by the FDA. Date of first approval: June 15, 2011.

What is the dosage and form of Nulojix® supplied?

Nulojix is supplied in lyophilized powder for injection: 250 mg per vial for intravenous (IV) use.

What are the most common side effects of Nulojix® injections?

The most common side effects of Nulojix® injection are urinary tract infection, anemia, diarrhea, cough, peripheral edema, pyrexia, constipation, hypertension, graft dysfunction, nausea, vomiting, hyperkalemia, headache, hypokalemia, and leukopenia.

How much does Nulojix® injection cost in India?

Prices of Nulojix injections may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Nulojix 25 mg injection cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Nulojix® injections be available in SAARC countries?

Apart from Gulf countries, Nulojix® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Nulojix® injections in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Nulojix® injections online in India?

Yes, one can buy Nulojix online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Nulojix® injections through legal channels.

What are the storage conditions of Nulojix® injections?

The lyophilized powder of Nulojix® is stored refrigerated at 2°C to 8°C (36°F to 46°F). Protect this drug from light. Store it in the original package until time of use.